Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPhysical Medicine, Rehab & TherapiesAetna back pain non-invasive coverage update | Ope…
    Ask Trek AI about this page
    CurrentAetnaPolicy 0232

    Back Pain - Non Invasive Treatments

    Customize your policy alerts

    Sign up for Aetna Policy 0232 alerts

    Get alerted when Policy 0232 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Aetna's clinical policy bulletin governing coverage and medical necessity of non‑invasive interventions for back pain, including selected therapies, devices, and procedures, for Aetna members and providers.

    Policy Summary
    PayerAetna
    PolicyBack Pain - Non Invasive Treatments
    Policy CodePolicy 0232
    Change TypeNo material changes
    Effective DateMar 25, 1998
    Last ReviewApr 26, 2023
    Next Review DateFeb 22, 2024
    Key ActionPrescribe back school and ensure it is conducted by a physical therapist or other appropriate recognized healthcare professional to meet medical necessity.
    SourceLink

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    ≥1Experimental / investigational items
    97110,97140,97530Example CPT codes covered
    S9117HCPCS back school code
    M54.00,M54.9Example ICD-10 codes
    small/low-qualityCommon study limitation
    1998-03-25Policy effective date

    Coverage and Medical Necessity Criteria

    Back school (medical necessity)

    Covered when ALL of the following are met

    Back school medical necessity: Back school is medically necessary for the treatment of persons with chronic or recurrent back pain when the program is prescribed by the member's doctor and is conducted by a physical therapist or other appropriate recognized healthcare professional.

    See CPB 0325 - Physical Therapy

    Therapeutic procedures and back school (conditional coverage)

    Covered when selection criteria are met

    Selected CPT/HCPCS services: Certain CPT and HCPCS services (for example, therapeutic exercises 97110; manual therapy 97140; therapeutic activities 97530; and back school S9117) are covered when selection criteria in this policy are met.

    97530 not covered for Khan Kinetic Treatment; see related policy CPB 0325 - Physical Therapy

    Experimental / Investigational interventions

    Not covered / Experimental and investigational

    Experimental/Investigational devices and therapies: The following interventions are considered experimental and investigational because effectiveness has not been established: quantitative muscle testing devices and specific branded isokinetic/isometric machines (MedX Lumbar and Cervical Extension Devices; Isostation B-200 Lumbar Dynamometer; Kin‑Com; Cybex Back System; Biodex System 3; JTECH Tracker Freedom Wireless Muscle Testing) and other listed interventions (auricular acupressure; cupping therapy; Dr. Ho’s 2‑in‑1 Decompression Belt; gabapentinoids excluding fibromyalgia indication; high‑frequency impulse therapy; intermittent vertical lumbar traction; Khan Kinetic Treatment; kinesiotaping; Orthotrac pneumatic vest; spinal adjusting instruments; sustained acoustic medicine).

    Hand-held dynamometers (e.g., Lafayette, Nicholas, Hoggan) are considered integral to manual muscle testing and are not separately reimbursed.

    Evidence-to-coverage considerations

    Coverage considerations based on evidence summarized in this section:

    gabapentinoids_for_CLBP: Use of gabapentinoids for chronic low back pain has very low to low-quality evidence of benefit and demonstrates significant risk of adverse effects; use should be limited and justified by clear clinical rationale.evidence: very low/low; harms: increased RR for dizziness, fatigue, cognitive and visual disturbances

    Supports restrictive coverage or utilization review prior to use

    device_therapies_HFIT_SAM: High-frequency impulse therapy (HFIT) and Sustained Acoustic Medicine (SAM) have preliminary small trials or systematic review data showing short-term functional or pain improvements, but evidence is insufficient for broad coverage without prior conservative therapy and objective outcome documentation.short-term RCT/pilot data

    May require prior authorization and documentation of baseline and follow-up functional measures (e.g., 6MWT, TUG, NRS, ODI)

    kinesiotaping_and_cupping:

    Back school delivered for occupational or employer-directed purposes may be excluded from coverage. Benefit plan language and related policy provisions (for example, CPB 0250 - Occupational Therapy and CPB 0198 - Work Hardening Programs) should be reviewed to determine whether a specific member’s back school visits are a covered benefit under the member’s plan.

    Current guideline guidance from the North American Spine Society (2020) states that traction is not recommended to provide clinically significant improvements in pain or function for patients with subacute or chronic low back pain (Grade of Recommendation: A), indicating that routine coverage of traction modalities for these indications is not supported by the guideline.

    The policy identifies specific HCPCS/CPT items and devices that are not covered for the indications listed. Examples include E0830 (ambulatory traction device) and K1004 (sustained acoustic medicine home ultrasonic device). Providers should reference the coding section for the full list when submitting claims for device- or procedure-based interventions.

    Systematic review evidence summarized in the policy shows that gabapentinoids (gabapentin, pregabalin) do not demonstrate clear benefit for chronic low back pain and are associated with an increased risk of adverse events (dizziness, fatigue, cognitive impairment, visual disturbances). Given the limited efficacy and documented harms, use of gabapentinoids for chronic low back pain should be approached cautiously and may be subject to utilization review or considered not medically necessary for this indication.

    Relevant CPT / HCPCS / ICD-10 Codes

    CPT Codes covered if criteria are metCPTCovered
    97110Therapeutic procedure, one or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility.
    97140Manual therapy techniques (e.g., mobilization/manipulation, manual lymphatic drainage, manual traction), one or more regions, each 15 minutes.
    97530Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes [not covered for Khan Kinetic Treatment].
    97012Application of a modality to 1 or more areas; traction, mechanical.
    97545Work hardening/conditioning; initial 2 hours.
    97546Each additional hour (List separately in addition to code for primary procedure).
    97750Physical performance test or measurement, with written report, each 15 minutes.
    CPT codes not covered for indications listed in the CPB / no specific code itemsmixedNot Covered
    Hand held dynamometerNo specific CPT code; listed as not covered for indications in the CPB.
    Auricular acupressureNo specific CPT code; listed among interventions for back pain.
    Cupping therapyNo specific CPT code; listed among interventions for back pain.
    GabapentinoidsNo specific CPT/HCPCS; pharmacologic agents listed as interventions (gabapentin, pregabalin).
    KinesiotapingNo specific CPT code; listed among interventions for back pain.
    HCPCS Codes covered if selection criteria are metHCPCSCovered
    S9117Back school, per visit.
    HCPCS Codes not covered for indications listed in the CPBHCPCSNot Covered
    E0830Ambulatory traction device, all types, each.
    K1004Low frequency ultrasonic diathermy treatment device for home use, includes all components and accessories (sustained acoustic medicine).
    ICD-10 Codes covered if selection criteria are metICD-10
    M54.00
    M54.9Dorsalgia

    Provider Responsibilities, Prior Authorization, and Billing Guidance

    Note

    Coverage tied to selection criteria for listed codes

    Certain CPT and HCPCS codes (for example, 97110, 97140, 97530, and HCPCS S9117) are covered only when the selection/medical necessity criteria in this policy are met; conversely, specific HCPCS/CPT items and named devices (for example, E0830 ambulatory traction device and K1004/Sustained Acoustic Medicine) are identified as not covered for the indications listed in this bulletin.

    • Covered if selection criteria are met: CPT 97110, 97140, 97530; HCPCS S9117 (back school) [[see cited chunks]]
    • Not covered / listed among noncovered devices: HCPCS E0830 (ambulatory traction device), K1004 (sustained acoustic medicine) and other listed devices
    Prior Authorization

    Prior authorization for home‑use / device therapies

    Devices described as prescription home‑use (for example, Sustained Acoustic Medicine) and device therapies with limited evidence (for example, HFIT) may require prior authorization and supporting documentation of prior conservative therapy and objective functional measures.

    Background and Rationale

    Quantitative (computerized) muscle testing devices and branded isokinetic/isometric machines (for example, MedX lumbar/cervical extension devices, Isostation B‑200, Kin‑Com, Cybex, Biodex, and systems such as JTECH Tracker) are referenced in the policy background. The policy notes limited evidence that these devices provide superior outcomes compared with manual muscle testing or standard exercise equipment, and several branded devices are listed among interventions considered investigational because effectiveness has not been established. Hand‑held dynamometers are described as portable tools integral to manual muscle testing and are not separately reimbursed.

    Device and Term Definitions

    Hand‑held dynamometer — Portable muscle-strength quantifiers
    DefinitionPortable devices (e.g., Lafayette, Nicholas, Hoggan) used to quantify muscle strength; the use of hand-held dynamometers is considered integral to manual muscle testing and is not separately reimbursed.
    ExamplesLafayette Manual Muscle Tester; Nicholas Manual Muscle Tester; Hoggan microFET.
    Reimbursement noteNo additional reimbursement provided when used as part of manual muscle testing; considered integral to manual testing.
    Isokinetic/isometric testing devices — Branded machines for testing and exercise
    DefinitionBranded isokinetic/isometric exercise and testing machines used for muscle testing and administering exercise therapy; examples include MedX, Cybex, Biodex, Kin‑Com, and Isostation models.
    Clinical evidence

    Policy History and Administrative Dates

    2023-04-26last_review

    Policy last reviewed on 04/26/2023; review notes recorded in policy history.

    1998-03-25effective_date

    Policy became effective on 03/25/1998.

    2024-02-22next_reviewLatest

    Next scheduled review date set for 02/22/2024.

    Policy Summary
    PayerAetna
    PolicyBack Pain - Non Invasive Treatments
    Policy CodePolicy 0232
    Change TypeNo material changes
    Effective DateMar 25, 1998
    Last ReviewApr 26, 2023
    Next Review DateFeb 22, 2024
    Key ActionPrescribe back school and ensure it is conducted by a physical therapist or other appropriate recognized healthcare professional to meet medical necessity.
    SourceLink
    On This Page
    Coverage and Medical Necessity CriteriaRelevant CPT / HCPCS / ICD-10 CodesProvider Responsibilities, Prior Authorization, and Billing GuidanceBackground and RationaleDevice and Term DefinitionsPolicy History and Administrative Dates
    Kinesiotaping and cupping demonstrate low-quality evidence of short-term pain and disability improvement in chronic nonspecific low back pain; methodological limitations and heterogeneity temper conclusions.
    GRADE: low

    Considered investigational or conditional depending on plan policy and demonstration of clinical benefit

    traction_vertical: Intermittent vertical lumbar traction provides very-low to low-quality evidence for short-term pain reduction in lumbar radiculopathy but does not improve activity limitation; major guidelines do not recommend traction for subacute or chronic low back pain.short-term up to 3 months; guideline evidence against routine traction

    Routine coverage not supported; may be considered only for select short-term indications after conservative measures

    • SAM is described as a prescription home‑use mechano‑transductive device and is listed among emerging device therapies.
    • HFIT and SAM have preliminary short‑term trial data; prior authorization may be required with documentation of baseline function and short‑term follow‑up measures (6MWT, TUG, NRS, ODI, PGIC).
    Note

    Prior authorization requirements not specified in this excerpt

    This excerpt of the policy does not specify concrete prior authorization procedures, affected billing codes, or stepwise authorization triggers; the document instead provides policy history and administrative information.

    • Policy history and review dates are listed (effective 03/25/1998; last review 04/26/2023; next review 02/22/2024).
    • No explicit prior authorization workflow or authorization triggers are defined in these chunks.
    Note

    Follow policy coverage criteria and plan benefit terms

    Providers should follow the policy's coverage criteria and documentation guidance when requesting services; the policy lists provider‑relevant actions (see other callouts) but does not add additional unspecified obligations in these chunks.

    • Adhere to coverage/medical necessity statements (e.g., back school must be prescribed and conducted by appropriate clinicians).
    • Check plan benefit descriptions for exclusions (e.g., occupational back school).
    Step Therapy

    Do not routinely substitute traction for active PT; consider only selective, short‑term use

    Traction modalities have limited and generally low‑quality evidence and should not routinely replace active physical therapy; traction may be considered only after appropriate conservative measures and for specific short‑term indications consistent with guideline recommendations.

    • Investigators reported insufficient high‑quality data to support routine benefit from intermittent vertical lumbar traction.
    • North American Spine Society (2020) guideline: traction is not recommended to provide clinically significant improvements in pain or function for subacute or chronic LBP (Grade A).
    Note

    No step therapy mandates specified

    No step therapy requirements (a mandated sequence of therapies) are described in the extracted policy chunks.

    • The policy provides evidence summaries and coverage considerations but does not set explicit step therapy rules in these excerpts.
    Documentation Required

    Prescribe and document clinician‑delivered back school

    Back school is medically necessary only when prescribed by the member's doctor and conducted by a physical therapist or other appropriate recognized healthcare professional; ensure prescriptions and provider credentials are documented.

    • Back school must be prescribed by the member’s doctor.
    • The program must be conducted by a physical therapist or other appropriate recognized healthcare professional.
    Documentation Required

    Document baseline and short‑term device outcome measures

    When proposing coverage for emerging or home‑use device therapies (for example HFIT or SAM), document baseline function and short‑term follow‑up outcome measures (such as 6MWT, TUG, NRS, ODI, PGIC) and record device usage to support clinical effect.

    • HFIT trial used 6MWT (primary), TUG, ODI, NRS, PGIC and weekly follow‑up for 4 weeks.
    • SAM systematic review reported functional measures (dynamometry, ROM), pain intensity and global change; document comparable baseline and follow‑up measures.
    Note

    Administrative disclaimer and provider responsibilities

    Clinical Policy Bulletins are administrative guidance and do not constitute offers of coverage or medical advice; participating providers remain responsible for treatment decisions and should check plan benefit terms for coverage determinations.

    • CPBs provide a general description of plan benefits and are subject to change.
    • Providers are independent contractors and responsible for medical advice and treatment of members.
    Denial Risk

    Verify coverage for occupational back school

    Back school provided for occupational purposes may be excluded from coverage depending on the member’s benefit plan; verify benefit plan descriptions before billing or providing services.

    • Policy explicitly notes back school for occupational purposes may be excluded (see CPB 0250 and CPB 0198).
    • Confirm member’s plan benefits for exclusions prior to authorization or delivery.
    Denial Risk

    Expect denials for experimental / investigational devices

    Interventions identified as experimental and investigational (including MedX, Isostation B‑200, Kin‑Com, Cybex, Biodex, JTECH Tracker Freedom and other listed devices/therapies) are considered not proven effective and may be denied as investigational.

    • Listed experimental devices: MedX Lumbar/Cervical, Isostation B‑200, Kin‑Com, Cybex Back System, Biodex System 3, JTECH Tracker Freedom.
    • Other listed investigational interventions include auricular acupressure, cupping, Khan Kinetic Treatment, Orthotrac vest, sustained acoustic medicine, etc.
    Denial Risk

    Prescribing gabapentinoids for CLBP may trigger utilization review

    Use of gabapentinoids (gabapentin, pregabalin) for chronic low back pain has limited evidence of benefit and increased risk of adverse events; prescribing these agents for CLBP may prompt utilization review or denial.

    • Systematic reviews found minimal or no clinically meaningful pain benefit and increased rates of dizziness, fatigue, cognitive difficulties and visual disturbances.
    • Authors concluded use of gabapentinoids for CLBP merits caution given lack of effectiveness and safety concerns.
    Note

    Authorization/denial triggers not specified here

    No specific authorization or denial triggers are provided in these chunks; the policy excerpts list review dates and administrative history but do not define discrete authorization/denial conditions beyond the coverage and investigational statements.

    • Policy history and review dates are presented (effective date, last review, next review).
    • Authorization/denial triggers beyond the policy's criteria and investigational listings are not specified in these excerpts.
    These devices can be used as medically necessary exercise alternatives in physical therapy but have not been proven superior to standard exercise equipment for functional outcomes.
    Examples in policyMedX Lumbar and Cervical Extension Devices; Isostation B-200 Lumbar Dynamometer; Kin‑Com Physical Therapy Isokinetic Equipment; Cybex Back System; Biodex System 3.
    Gabapentinoids — gabapentin and pregabalin in chronic low back pain
    Class membersGabapentin and pregabalin (gabapentinoids).
    Evidence summarySystematic review/meta-analysis found very low to low-quality evidence of minimal or no benefit for chronic low back pain (CLBP).
    Safety concernsAssociated with increased risk of adverse events including dizziness, fatigue, cognitive/mentation difficulties, and visual disturbances (noted RRs and NNHs in trials).
    Sustained Acoustic Medicine (SAM) — prescription home‑use ultrasound device
    DefinitionA prescription home‑use mechano‑transductive device delivering sustained ultrasound intended to stimulate tissue recovery, increase micro‑streaming/cavitation, and reduce musculoskeletal pain.
    Device parameters (example)Reported in literature as delivering ultrasound (e.g., 3 MHz at 1.3 W) in home‑use protocols.
    Evidence summarySystematic review of clinical studies (13 studies, n=372) reported tissue heating, functional improvements, and pain reduction, but evidence is limited and emerging.
    High‑Frequency Impulse Therapy (HFIT) — pilot RCT evidence
    DefinitionA device‑based therapy evaluated in a small randomized, multi‑center pilot RCT for chronic low back pain comparing HFIT versus sham.
    Key trial findingsIn a 36‑patient pilot RCT, HFIT users showed short‑term improvements in 6MWT, TUG, and NRS at 2–4 weeks versus baseline; authors called for larger RCTs.
    Evidence implicationPreliminary and insufficient for broad coverage without further confirmation from larger trials and documented functional benefit.
    Quantitative muscle testing devices / Back schools / Orthotrac Pneumatic Vest — referenced intervention categories
    Referenced categoriesQuantitative/computerized muscle testing devices; Back schools; Orthotrac pneumatic vest (pneumatic decompression device).
    Evidence contextThese interventions are cited in the references with multiple small studies and mixed results; computerized muscle testing has not shown improved clinical outcomes over manual testing.
    Policy positionSpecific branded quantitative muscle testing devices and Orthotrac are listed among interventions considered experimental/investigational due to insufficient evidence of effectiveness.